Article

Haematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-line Treatment With a Bortezomib-based Regimen

2020-06-16

Abstract excerpt

<title>Abstract</title> <p><bold>Backgroud: </bold>It is very important to evaluate the prognosis of multiple myeloma (MM) patients before starting treatment. Although haematopoietic status may have a significant impact on patient survival, it has not received sufficient attention in current clinical practice.<bold>Methods:</bold>This was a retrospective study of 150 newly diagnosed MM patients treated in one hem...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 49893d0f-b984-5606-823c-bd580e33da47
DOI: 10.21203/rs.3.rs-35129/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Haematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-line Treatment With a Bortezomib-based RegimenDOI 10.21203/rs.3.rs-35129/v1Read

Hematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-Line Treatment With A Bortezomib-Based RegimenSemantic proximity Read

Increased LDH Remains a Crucial Prognostic Factor in Patients with Multiple Myeloma.Semantic proximity Read

Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases.Semantic proximity Read

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaSemantic proximity Read

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantationSemantic proximity Read

Treatment outcome of newly diagnosed multiple myeloma patients: A retrospective analysis in a resource-limited settingSemantic proximity Read

Current Review on High-Risk Multiple Myeloma.Semantic proximity Read

Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained responseSemantic proximity Read

Applications of Multiparameter Flow Cytometry in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma PatientsSemantic proximity Read

Functional high-risk phenotype predicts poor survival in multiple myeloma independent of front-line treatment: A secondary analysis of CIBMTR data.Semantic proximity Read

Pattern of Use and Efficacy of Daratumumab-based Therapy in Patients With Multiple Myeloma in a Real-world Setting: a Single Institution ExperienceSemantic proximity Read

Management of high-risk Myeloma: an evidence-based review of treatment strategies.Semantic proximity Read